Literature DB >> 3598620

Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.

K Watne, B Hager.   

Abstract

A 65 year old woman presented with a recurrent locally advanced esthesioneuroblastoma. She had earlier been treated with radiation followed by surgery. The recurrence was located in earlier radiated tissues with intracranial infiltration. She underwent treatment with combined intra-arterial chemotherapy (BCNU) i.a., vincristine i.v., procarbazine orally). 6 courses of chemotherapy were given with complete remission. The patient is free of disease and asymptomatic 24 months after treatment.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3598620     DOI： 10.1007/bf00162764

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  9 in total

1.  Ultrastructure of the esthesioneuroblastoma.

Authors:  R Y Osamura; G Fine
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

Review 2.  Esthesioneuroblastoma.

Authors:  D Elkon; S I Hightower; M L Lim; R W Cantrell; W C Constable
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

3.  Olfactory neuroblastoma. Management and prognosis.

Authors:  B J Bailey; S Barton
Journal:  Arch Otolaryngol       Date:  1975-01

Review 4.  Response of esthesioneuroblastoma to chemotherapy. Report of five cases and review of the literature.

Authors:  P M Wade; R E Smith; M E Johns
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

5.  Brain radiation necrosis following treatment of an esthesioneuroblastoma (olfactory neurocytoma).

Authors:  S H Baron
Journal:  Laryngoscope       Date:  1979-02       Impact factor: 3.325

6.  Role of radiation therapy in the treatment of olfactory neuroblastoma.

Authors:  K Ahmad; J V Fayos
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-03       Impact factor: 7.038

7.  Cerebral necrosis following radiotherapy of extracranial neoplasms.

Authors:  D A Rottenberg; N L Chernik; M D Deck; F Ellis; J B Posner
Journal:  Ann Neurol       Date:  1977-04       Impact factor: 10.422

8.  Olfactory neuroblastoma: an ultrastructural study.

Authors:  J B Taxy; D F Hidvegi
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

9.  Treatment of advanced esthesioneuroblastoma with high-dose chemotherapy and autologous bone marrow transplantation. A case report.

Authors:  G T O'Conor; C R Drake; M E Johns; W S Cail; H R Winn; E Niskanen
Journal:  Cancer       Date:  1985-01-15       Impact factor: 6.860
  9 in total
  2 in total

Review 1.  Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature.

Authors:  Michael C Park; Charles E Weaver; John E Donahue; Prakash Sampath
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

Review 2.  Chemotherapy for cranial base tumors.

Authors:  H E Jacob
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.